((1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy- 1,4-imino-D-ribitol
|
|
(-)-epigallocatechin gallate
|
|
(3R,4R)-1-((2-amino-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-ium
|
|
(methoxyphenyl)inosine
|
|
2'-deoxy ImmG
|
|
2'-deoxy ImmH
|
|
4’-Deaza-1’- Aza-2’-Deoxy-1’-(9-Methylene)-Immucillin-G |
|
5-(m-benzyloxy) benzylbarbituric acid
|
|
Adenosine
|
|
Bcx-4945
|
|
Biochemical and biophysical characterization, suggested target |
|
Citrinin
|
|
DADMe-ImmG
|
|
Guanosine
|
|
His-His-Asp-Gly-Asn-Gln-Cys-His-Cys-Asp)
|
|
Immucillin
|
|
Immucillin H
|
|
Immucillin-H
|
|
Lupeol
|
|
Methylthio-immucillin-h
|
|
Mt-immh
|
|
MT-ImmH
|
|
N-bromosuccinamide
|
|
Quinine
|
|
Suggested target
|
|
Uracil equivalents of purine-based pnp transition state inhibitors |
|
ZINC09933332
|
|
ZINC12088418
|
|
ZINC78322339 |
|
ZINC89866699
|
|